Imexpharm Corp.

30
Sell
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: VN000000IMP0
VND
53,900.00
500 (0.94%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Imexpharm Corp. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
446,247.00
404,192.00
377,272.00
291,404.00
238,859.00
255,441.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-378,113.00
-215,510.00
-390,139.00
97,235.00
3,693.00
-189,094.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
73,441.00
223,942.00
-17,717.00
394,864.00
240,043.00
79,737.00
Cash Flow from Investing Activities
-95,854.00
-134,874.00
57,303.00
-217,097.00
-93,248.00
-143,060.00
Cash Flow from Financing Activities
49,653.00
-33,304.00
-112,229.00
-271,718.00
34,495.00
73,592.00
Net Cash Inflow / Outflow
27,209.00
55,782.00
-72,644.00
-93,960.00
181,060.00
10,306.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
-30.00
19.00
0.00
-9.00
-230.00
36.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in VND Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Imexpharm Corp.
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(VND)
Change(%)
Profit Before Tax
446247.738093
904484.566816
-4,58,237.00
-50.66%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-378113.779785
478383.501874
-8,56,496.00
-179.04%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
73441.552898
1474369.198406
-14,00,928.00
-95.02%
Cash Flow from Investing Activities
-95854.054491
-602736.987502
5,06,882.00
84.10%
Cash Flow from Financing Activities
49653.073103
-902846.163646
9,52,499.00
105.50%
Net Cash Inflow / Outflow
27209.909578
-31276.478746
58,485.00
187.00%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-30.661932
-62.526004
32.00
50.96%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
stock-summary

YoY Growth in year ended Dec 2025 is -67.21% vs 1,363.95% in Dec 2024

Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
73,441.55
2,23,942.75
-67.21%